MITO
Stealth BioTherapeutics Corp. ADS
MITO
MITO
Delisted
MITO was delisted on the 15th of November, 2022.
12 hedge funds and large institutions have $1.26M invested in Stealth BioTherapeutics Corp. ADS in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
Holders
12
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$138K | |
| 2 | +$35K | |
| 3 | +$23K | |
| 4 |
PAM
PVG Asset Management
Golden,
Colorado
|
+$18.7K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$16.5K |
Top Sellers
| 1 | -$1.25M | |
| 2 | -$473K | |
| 3 | -$468K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$177K |
| 5 |
Squarepoint
New York
|
-$100K |